Add-on therapy for hypercholesterolemia: a pilot comparison of two gastrointestinally-acting agents in statin-treated patients

Journal of Clinical Lipidology

Volumn 3, Issue 2, 2009, Pages 119-124

  Zema, Michael James ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Colesevelam; Ezetimibe; LDL C; Non HDL C; Statin; Synergy

Indexed keywords

ATORVASTATIN; COLESEVELAM; EZETIMIBE; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ADD ON THERAPY; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION;

EID: 61949332790     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.02.008     Document Type: Article

References (26)

1. Welchol (colesevelam hydrochloride) (package insert) (2008), Daiichi Sankyo Inc, Parsippany, NJ
2. Dujovne C.A., Ettinger M.P., McNeer J.F., et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 90 (2002) 1092-1097
3. Knopp R.H., Gitter H., Truitt T., et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 24 (2003) 729-741
4. Zetia (ezetimibe) (package insert) (2008), Merck/Schering-Plough Pharmaceuticals, North Wales, PA
5. Ballantyne C.M., Weiss R., Moccetti T., et al. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study). Am J Cardiol 99 (2007) 673-680
6. Bays H.E., Davidson M., Jones M.R., and Abby S.L. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Am J Cardiol 97 (2006) 1198-1205
7. Bissonnette S., Habib R., Sampalis F., Boukas S., and Sampalis J.S. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: a Canadian, multicentre, prospective study-the Ezetrol Add-On Study. Can J Cardiol 22 (2006) 1035-1044
8. Davidson M.H., Toth P., Weiss S., et al. Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Clin Cardiol 24 (2001) 467-474
9. Gagne C., Bays H.E., Weiss S.R., et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 90 (2002) 1084-1091
10. Hunninghake D., Insull Jr. W., Toth P., Davidson D., Donovan J.M., and Burke S.K. Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. Atherosclerosis 158 (2001) 407-416
11. Knapp H.H., Schrott H., Ma P., et al. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Am J Med 110 (2001) 352-360
12. Mikhailidis D.P., Sibbring G.C., Ballantyne C.M., Davies G.M., and Catapano A.L. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin 23 (2007) 2009-2026
13. Pearson T.A., Denke M.A., McBride P.E., Battisti W.P., Brady W.E., and Palmisano J. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 80 (2005) 587-595
14. Briand F., Serisier S., Krempf M., et al. Atorvastatin increases intestinal cholesterol absorption in dogs. J Nutr 136 (2006) 2034S-2036S
15. Miettinen T.A., and Gylling H. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Invest 33 (2003) 976-982
16. Sudhop T., Lutjohann D., Kodal A., et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106 (2002) 1943-1948
17. McNamara D.J., Davidson N.O., Samuel P., and Ahrens E.H. Jr. Cholesterol absorption in man: effect of administration of clofibrate and/or cholestyramine. J Lipid Res 21 (1980) 1058-1064
18. Donovan J.M., von Bergmann K., Setchell K.D., et al. Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia. Dig Dis Sci 50 (2005) 1232-1238
19. Myers G.L., Cooper G.R., Winn C.L., and Smith S.J. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 9 (1989) 105-135
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Kannel W.B. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 76 (1995) 69C-77C
22. Davidson M.H., Maki K.C., Pearson T.A., et al. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol 96 (2005) 556-563
23. Pearson T.A., Laurora I., Chu H., and Kafonek S. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
24. Ballantyne C.M., Houri J., Notarbartolo A., et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 107 (2003) 2409-2415
25. Davidson M.H., McGarry T., Bettis R., et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 40 (2002) 2125-2134
26. Schectman G., and Hiatt J. Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment. Ann Intern Med 125 (1996) 990-1000